Drugs / PF-06423264
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02778477 | May 2016 → May 2017 | — | Pfizer | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06423264 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02778477 ↗ |
| Route | Topical | “administered topically” NCT02778477 ↗ |